{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:15:35Z","timestamp":1774581335226,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"International Center for Genetic Engineering and Biotechnology (ICGEB, Trieste, Italy)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.vaccine.2014.02.041","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T02:00:32Z","timestamp":1393380032000},"page":"2808-2811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development of a vectored vaccine against Hepatitis E virus"],"prefix":"10.1016","volume":"32","author":[{"given":"Khaled","family":"Trabelsi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amine","family":"Kamen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9la","family":"Kallel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2014.02.041_bib0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0042-6822(91)90760-9","article-title":"Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome","volume":"185","author":"Tam","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.02.041_bib0010","series-title":"Fields virology","first-page":"3047","article-title":"virus","author":"Emerson","year":"2007"},{"issue":"1","key":"10.1016\/j.vaccine.2014.02.041_bib0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1440-1746.2010.06540.x","article-title":"Hepatitis E: historical, contemporary and future perspectives","author":"Aggarwal","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2014.02.041_bib0020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12072-008-9071-4","article-title":"Vaccine","volume":"2","author":"Aggarwal","year":"2008","journal-title":"Hepatol Int"},{"key":"10.1016\/j.vaccine.2014.02.041_bib0025","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","article-title":"Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial","volume":"376","author":"Zhu","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.02.041_bib0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2144\/03342bm05","article-title":"Titration of non-occluded baculovirus using a cell viability assay","volume":"34","author":"Graentzdoerffer","year":"2003","journal-title":"BioTechniques"},{"key":"10.1016\/j.vaccine.2014.02.041_bib0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0166-0934(02)00128-3","article-title":"Quantitation of baculovirus particles by flow cytometry","volume":"105","author":"Shen","year":"2002","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2014.02.041_bib0040","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2144\/000113238","article-title":"A rapid method for titrating baculovirus stocks using the Sf-9 easy titer cell line","volume":"47","author":"Hopkins","year":"2009","journal-title":"BioTechniques"},{"key":"10.1016\/j.vaccine.2014.02.041_bib0045","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/bit.21069","article-title":"Production of adeno-associated viral vectors in insect cells using triple infection: optimisation of baculovirus concentration ratios","volume":"95","author":"Aucoin","year":"2006","journal-title":"Biotechnol Bioeng"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1400214X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1400214X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T20:03:58Z","timestamp":1565208238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1400214X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":9,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0264410X1400214X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a vectored vaccine against Hepatitis E virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}